ArticleVirology journal2025
Two novel polyvalent phages: a promising approach for cross-order pathogen control in aquaculture.
Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Genomic characterization and phage cocktail suppression of a multidrug-resistantApplied and environmental microbiology · 2026Article
- Isolation and characterization of a novel Schitoviridae phage VipHU7 that infects Vibrio parahaemolyticus.Archives of virology · 2026Article
- Isolation and characterization of novel bacteriophages with broad-spectrum lytic activity against carbapenem-resistant Klebsiella pneumoniae capsular pathotypes K1, K2, K3, K5, and K20.Biology direct · 2026Article
- Enhanced control of pathogenicApplied and environmental microbiology · 2025Article
- SXP01: a novel bacteriophage for combatingFrontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Bacteriophages represent a promising alternative to antibiotics for controlling bacterial pathogens. However, phage application is often hindered by its narrow host range in preventing diseases caused by multiple unknown pathogens. While broad-host-range phages capable of cross-genus or cross-order infections, offer significant advantages in addressing this challenge, they are rarely isolated. In this study, we isolated two polyvalent lytic phages, SA-P and SA-M, through a multi-host enrichment strategy. These phages exhibited remarkable cross-order infectivity against the co-occurring aquaculture pathogens Shewanella algae and multiple Vibrio species. We confirmed that SA-P executes a complete lytic cycle in these cross-order hosts, indicating exceptional compatibility of its lysis systems across taxonomic orders. Genomic analysis revealed that their broad host recognition ability may stem from their diverse tail fiber and tailspike proteins. Notably, SA-P and SA-M are the first phages reported to infect S. algae, and their combined application exhibited a sustained suppression of pathogen growth. Proteomic phylogenetic analysis suggests these phages represent a novel unclassified viral genus and family, respectively. This study provides two promising polyvalent phages and their cocktails as potential solution for cross-order pathogen control in aquaculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.